Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 3.97 | 2.21 | 27.73 | 39.52 |
Depreciation/ Depletion | 7.49 | 10.99 | 10.25 | 9.18 |
Non- Cash Items | 6.45 | 12.93 | 12.12 | 8.06 |
Changesin Working Capital | -14.28 | 13.39 | -24.40 | -29.21 |
Cashfrom Operating Activities | 3.64 | 39.52 | 25.71 | 27.55 |
Capital Expenditures | -11.83 | -27.91 | -27.67 | -31.44 |
Other Investing Cash Flow Items Total | 0.01 | 5.74 | 0.34 | 0.15 |
Cashfrom Investing Activities | -11.83 | -22.17 | -27.33 | -31.29 |
Financing Cash Flow Items | -7.26 | -12.75 | -11.16 | -9.33 |
Issuance( Retirement)of Debt Net | 12.49 | -3.87 | 14.14 | 12.02 |
Cashfrom Financing Activities | 5.23 | -16.62 | 2.98 | 2.70 |
Net Changein Cash | -2.96 | 0.73 | 1.36 | -1.04 |
Cash Interest Paid | 7.26 | 12.75 | 11.16 | 9.33 |
Cash Taxes Paid | 0.09 | -0.03 | 8.81 | 9.27 |
Issuance( Retirement)of Stock Net | - | - | 0.00 | - |
Mangalam Drugs & Organics Dividend Mangalam Drugs & Organics Bonus Mangalam Drugs & Organics News Mangalam Drugs & Organics AGM Mangalam Drugs & Organics Rights Mangalam Drugs & Organics Splits Mangalam Drugs & Organics Board Meetings Mangalam Drugs & Organics Key Metrics Mangalam Drugs & Organics Shareholdings Mangalam Drugs & Organics Profit Loss Mangalam Drugs & Organics Balance Sheet Mangalam Drugs & Organics Q1 Results Mangalam Drugs & Organics Q2 Results Mangalam Drugs & Organics Q3 Results Mangalam Drugs & Organics Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks